Categories
approves Australia

Australia approves Novavax COVID-19 vaccine and new COVID oral drug treatments

The national drug regulator has given the green light to the Novavax vaccine, along with two oral treatments for patients currently suffering from COVID-19. The Therapeutic Goods Administration (TGA) on Thursday approved the Novavax vaccine, also called Nuvaxovid, for adults aged 18 years and over, making it the first protein-based COVID-19 vaccine in the country’s…

The national drug regulator has given the green light to the Novavax vaccine, along with two oral treatments for patients currently suffering from COVID-19.

The Therapeutic Goods Administration (TGA) on Thursday approved the Novavax vaccine, also called Nuvaxovid, for adults aged 18 years and over, making it the first protein-based COVID-19 vaccine in the country’s arsenal.

It is not recommended to be used as the primary vaccine, as Novavax booster shots are still being studied.

Health Minister Greg Hunt Thursday stated that he hopes the new jab will increase the country’s vaccination rates.

” We know some people have waited to get this vaccine and… hopefully this will encourage them to come forward,” Hunt stated.

He stated that the government had obtained 51 millions doses of the vaccine. The first batch will arrive in the next month.

The jab, which is administered in two doses three weeks apart, will be available at state clinics as well as GPs and pharmacies.

Professor John,

TGA boss, stated that his agency was the second largest regulator in the world to approve the protein-based vaccination. He also noted that the vaccine was manufactured using an “old technology .”

“.

” I would have received several hundred emails from people and groups saying that they would like [this] a particular vaccine. This just gives them more options,” Skerritt said to reporters.

” Our dream is to make 95% (vaccination rate), 97, or 98 .

He said that the vaccine was more than 90 effective with no strong signs of adverse events .”

Novavax still needs to be approved by the Australian Technical Advisory Group on Immunisation, which will determine who is eligible for the vaccine.

The protein vaccine uses a non-infectious ingredient found on the surface novel coronavirus.

After vaccination, immune cells recognize the vaccine protein and initiate an immune response.

Novavax is the fifth vacc

Read More

Leave a Reply

Your email address will not be published.